TSHA vs TVGN

Taysha Gene Therapies, Inc. vs Tevogen Bio Holdings Inc. — Valuation Comparison 2026

TSHA

Biotechnology
Taysha Gene Therapies, Inc.
Quality
6.0
out of 10
Value Trap
18
SAFE
Price
$5.92
Last close
Models
9/13
Active
VS

TVGN

Biotechnology
Tevogen Bio Holdings Inc.
Quality
3.0
out of 10
Value Trap
24
SAFE
Price
$8.04
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType TSHA Fair ValueTSHA Upside TVGN Fair ValueTVGN Upside
Bayesian DCF Intrinsic $2.02 -65.8% $1.95 -75.7%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.05 -82.3% $0.41 -94.9%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TSHA vs TVGN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TSHA vs TVGN — Which Stock Is More Undervalued?

TSHA scores higher with a 6.0/10 quality rating vs TVGN's 3.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Taysha Gene Therapies, Inc. (TSHA) and Tevogen Bio Holdings Inc. (TVGN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TSHA currently trades at $5.92 with a QOC of 6.0/10, while TVGN trades at $8.04 with a QOC of 3.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).